sentenza 26 giugno 1985; Giud. Benini; imp. Ceccherini e altro

Publikováno v: Il Foro Italiano, 1986 Mar 01. 109(3), 191/192-195/196.

Externí odkaz: https://www.jstor.org/stable/23180264

Type-specific inflammatory responses of vascular cells activated by interaction with virgin and aged microplastics

Autor: Lomonaco, T., Persiani, E., Biagini, D., Gisone, I., Ceccherini, E., Cecchettini, A., Corti, A., Ghimenti, S., Francesco, F. Di, Castelvetro, V., Vozzi, F.

Publikováno v: In Ecotoxicology and Environmental Safety 1 September 2024 282

Novel in vitro evidence on the beneficial effect of quercetin treatment in vascular calcification.

Autor: Ceccherini, E., Gisone, I., Persiani, E., Ippolito, C., Falleni, A., Cecchettini, A., Vozzi, F.

Publikováno v: Frontiers in Pharmacology; 2024, p1-10, 10p

Targeting autophagy impairment improves the phenotype of a novel CLN8 zebrafish model.

Autor: Marchese M; Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy. Electronic address: maria.marchese2086@gmail.com., Bernardi S; Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy; Department of Biology, University of Pisa, Pisa, Italy., Ogi A; Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy., Licitra R; Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy., Silvi G; Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy., Mero S; Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy., Galatolo D; Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy., Gammaldi N; Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy., Doccini S; Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy., Ratto GM; National Enterprise for NanoScience and NanoTechnology (NEST), Istituto Nanoscienze, Consiglio Nazionale delle Ricerche (CNR) and Scuola Normale Superiore, Pisa, Italy., Rapposelli S; University of Pisa, Department of Pharmacy, Pisa, Italy., Neuhauss SCF; University of Zurich, Department of Molecular Life Sciences, Zurich, Switzerland., Zang J; University of Zurich, Department of Molecular Life Sciences, Zurich, Switzerland., Rocchiccioli S; Institute of Clinical Physiology, National Research Council, Pisa, Italy., Michelucci E; Institute of Clinical Physiology, National Research Council, Pisa, Italy; Institute of Chemistry of Organometallic Compounds, National Research Council, Pisa, Italy., Ceccherini E; Institute of Clinical Physiology, National Research Council, Pisa, Italy., Santorelli FM; Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone, Pisa, Italy. Electronic address: filippo3364@gmail.com.

Publikováno v: Neurobiology of disease [Neurobiol Dis] 2024 Jul; Vol. 197, pp. 106536. Date of Electronic Publication: 2024 May 17.

Proof of concept of a new plasma complement Factor H from waste plasma fraction.

Autor: Mori F; Research and Innovation, Kedrion Biopharma, Lucca, Italy., Pascali G; Biosciences, Australian Nuclear Science and Technology Organisation, Lucas Heights, NSW, Australia.; School of Chemistry, University of New South Wales, Kensington, NSW, Australia., Berra S; Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Milan, Italy., Lazzarotti A; Research and Innovation, Kedrion Biopharma, Lucca, Italy., Panetta D; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Rocchiccioli S; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Ceccherini E; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Norelli F; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Morlando A; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Donadelli R; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Clivio A; Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Milan, Italy., Farina C; Research and Innovation, Kedrion Biopharma, Lucca, Italy., Noris M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Salvadori PA; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Remuzzi G; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Jun 06; Vol. 15, pp. 1334151. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).